ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate - PubMed (original) (raw)

ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate

N Altiok et al. EMBO J. 1995.

Abstract

Motor neurons modulate acetylcholine receptor (AChR) gene expression in skeletal muscle by two signalling pathways: the transmitter-evoked depolarization of muscle membrane inhibits AChR gene transcription throughout the myofibre presumably via activation of a serine/threonine kinase, while the transcription rates of AChR genes in the synaptic region are increased by nerve-derived trophic factors including AChR-inducing activity (ARIA). To gain further insight into these interactions we characterized the receptor for heregulin (HRG)/ARIA in muscle. We showed that HRG increases AChR alpha-subunit mRNA levels via tyrosine phosphorylation of ErbB3 and ErbB2/neu in myotubes. The protein tyrosine phosphatase inhibitor, pervanadate, potentiated the responses to HRG that were in turn blocked by the tyrosine kinase inhibitor erstatin, indicating the relevance of tyrosine phosphorylation to these events. The effects of HRG were inhibited by enhanced cellular serine/threonine phosphorylation which has been implicated in the repression of AChR genes by electrical activity. Immunocytochemical analysis of adult rat muscle revealed that while ErbB2/neu is present throughout the entire surface of the myofibre membrane, ErbB3 expression is exclusively restricted to the endplate suggesting its involvement in synapse-specific transcription of AChR genes by HRG/ARIA.

PubMed Disclaimer

Cited by

Theranostic potential of a novel aptamer specifically targeting HER2 in breast cancer cells.
Küçükcankurt F, Uçak S, Altiok N. Küçükcankurt F, et al. Turk J Biol. 2024 Feb 1;48(1):35-45. doi: 10.55730/1300-0152.2680. eCollection 2024. Turk J Biol. 2024. PMID: 38665781 Free PMC article.
Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis.
Chia R, Saez-Atienzar S, Drachman DB, Traynor BJ. Chia R, et al. Proc Natl Acad Sci U S A. 2022 Sep 9;119(36):e2209096119. doi: 10.1073/pnas.2209096119. Epub 2022 Aug 15. Proc Natl Acad Sci U S A. 2022. PMID: 35969799 Free PMC article. No abstract available.
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
Chia R, Saez-Atienzar S, Murphy N, Chiò A, Blauwendraat C; International Myasthenia Gravis Genomics Consortium; Roda RH, Tienari PJ, Kaminski HJ, Ricciardi R, Guida M, De Rosa A, Petrucci L, Evoli A, Provenzano C, Drachman DB, Traynor BJ. Chia R, et al. Proc Natl Acad Sci U S A. 2022 Feb 1;119(5):e2108672119. doi: 10.1073/pnas.2108672119. Proc Natl Acad Sci U S A. 2022. PMID: 35074870 Free PMC article.
Neuregulin, an Effector on Mitochondria Metabolism That Preserves Insulin Sensitivity.
Gumà A, Díaz-Sáez F, Camps M, Zorzano A. Gumà A, et al. Front Physiol. 2020 Jun 23;11:696. doi: 10.3389/fphys.2020.00696. eCollection 2020. Front Physiol. 2020. PMID: 32655416 Free PMC article. Review.
Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction.
Singhal N, Martin PT. Singhal N, et al. Dev Neurobiol. 2011 Nov;71(11):982-1005. doi: 10.1002/dneu.20953. Dev Neurobiol. 2011. PMID: 21766463 Free PMC article. Review.

References

1. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9193-7 - PubMed
1. Nature. 1993 Mar 25;362(6418):312-8 - PubMed
1. Neuron. 1989 Mar;2(3):1229-36 - PubMed
1. Neuron. 1989 Apr;2(4):1295-300 - PubMed
1. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2900-4 - PubMed

ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate - PubMed (original) (raw)